Nassim Djebli

IN VITRO METABOLISM STUDY OF BUPRENORPHINE: EVIDENCE FOR NEW METABOLIC PATHWAYS

Nicolas Picard, Thierry Cresteil, Nassim Djebli et al. · Drug Metabolism and Disposition · 2005 · 147 citations

Medicine, Biochemistry, Pharmacology +17

CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients

Yannick Le Meur, Nassim Djebli, Jean-Christophe Szelag et al. · Clinical Pharmacology & Therapeutics · 2006 · 121 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients

Nassim Djebli, Nicolas Picard, Jean-Philippe Rérolle et al. · Pharmacogenetics and Genomics · 2007 · 77 citations

Medicine, Biochemistry, Pharmacology +17

Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients

Nassim Djebli, Annick Rousseau, Guillaume Hoizey et al. · Clinical Pharmacokinetics · 2006 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics

Nassim Djebli, David Fabre, Xavier Boulenc et al. · Drug Metabolism and Disposition · 2015 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +17